Timetable: Initial (full) marketing authorisation application accelerated assessment timetables - Advanced therapy medicinal product (ATMP)

Timetable: Initial (full) marketing authorisation application accelerated assessment timetables - Advanced therapy medicinal product (ATMP)

Human medicines European public assessment report (EPAR): Pheburane, sodium phenylbutyrate, Date of authorisation: 30/07/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR): Pheburane, sodium phenylbutyrate, Date of authorisation: 30/07/2013, Revision: 13, Status: Authorised

Policy 44: European Medicines Agency policy on the handling of competing interests of scientific committees’ members and experts - As adopted by EMA Management Board on 11-12 December 2024

Policy 44: European Medicines Agency policy on the handling of competing interests of scientific committees’ members and experts - As adopted by EMA Management Board on 11-12 December 2024

Policy 58: European Medicines Agency policy on the handling of competing interests of Management Board members - As adopted by EMA Management Board on 11-12 December 2024

Policy 58: European Medicines Agency policy on the handling of competing interests of Management Board members - As adopted by EMA Management Board on 11-12 December 2024

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness